Key result
Culprit artery occlusion in NSTEMI is linked to higher short-term major cardiovascular events but not long-term mortality.
Why the study?
A significant subset of NSTEMI patients presents with complete culprit artery occlusion, raising concerns regarding under-recognition and its prognostic implications on mortality and MACE.
Does complete culprit artery occlusion (TIMI 0-1) increase mortality and major adverse cardiovascular events (MACE) compared to non-occluded arteries (TIMI 2-3) in patients with NSTEMI?
Systematic Review
Does complete culprit artery occlusion (TIMI 0-1) increase mortality and major adverse cardiovascular events (MACE) compared to non-occluded arteries (TIMI 2-3) in patients with NSTEMI?
Complete culprit artery occlusion occurs in 14% to 29% of NSTEMI patients and is associated with higher short-term MACE and procedural risk in large registries, though long-term prognostic impact remains inconsistent.
Answers are grounded in this paper and cite their sources.
Supports heightened early risk awareness in NSTEMI without yet warranting routine urgent invasive strategies; leaves open whether noninvasive markers can identify complete occlusion pre-angiography.
Background: Non–ST-segment elevation myocardial infarction (NSTEMI) is traditionally considered a consequence of partial coronary occlusion. However, a significant subset of patients presents with complete culprit artery occlusion, raising concerns regarding under-recognition and its prognostic implications. This study aims to evaluate the impact of culprit artery occlusion on clinical outcomes, including mortality and major adverse cardiovascular events (MACE), in patients with NSTEMI. Methods: A systematic review was conducted in accordance with PRISMA 2020 guidelines. A comprehensive search of PubMed, Cochrane Library, and ScienceDirect databases was performed. Studies comparing NSTEMI patients with occluded culprit arteries (TIMI 0–1) versus non-occluded arteries (TIMI 2–3) and reporting clinical outcomes were included. Data were extracted and synthesized qualitatively due to heterogeneity across studies. Results: Seven observational studies were included. The prevalence of culprit artery occlusion ranged from 14% to 29%. Larger registry-based studies demonstrated increased short-term risk, including higher MACE and procedural complications in the occlusion group. However, smaller cohort studies showed no significant differences in mortality or long-term outcomes between groups. Overall, findings were heterogeneous, with no consistent association between occlusion and long-term prognosis. Conclusion: While occlusion identifies a higher-risk subgroup in the acute phase, it should not be used as an isolated prognostic marker. Individualized risk assessment remains essential in guiding management strategies.
No takes yet. Share an insight, caveat, or question.
Lola et al. (2026) conducted a systematic review in Non-ST-segment elevation myocardial infarction (NSTEMI). Occluded culprit artery (TIMI 0-1) vs. Non-occluded culprit artery (TIMI 2-3) was evaluated on Mortality and major adverse cardiovascular events (MACE). Culprit artery occlusion in NSTEMI increased short-term major cardiovascular events in large registries but had no consistent association with long-term mortality across 7 studies.
Synapse has enriched 10 related papers. Consider them for comparative context: